Healthy Louisiana Substance Use Disorder 1115 Demonstration Waiver
To maintain access to care for beneficiaries in need of Opioid Use Disorder and Substance Use Disorder (OUD/SUD) services in residential facilities, Louisiana applied for and received approval of an 1115 Demonstration Waiver, effective February 1, 2018 through December 31, 2022. The waiver is necessary to provide services to beneficiaries residing in Institutions for Mental Disease (IMDs) for stays with durations longer than 15 days. An IMD is a hospital, nursing facility, or other institution of more than 16 beds that is primarily engaged in providing diagnosis, treatment or care of persons with mental diseases. CMS allowed the traditionally excluded use of IMDs but placed a day limit of 15 days on its usage. This waiver “waived” the cap of 15 days for Louisiana. As a result of waiver approval, Louisiana is able to receive federal financial participation (FFP), i.e. the Medicaid match, for the continuum of services to treat addictions to opioids and other substances.
2023 Annual Public Forum
Pursuant to 42 CFR 431.420(c), the Louisiana Department of Health will hold a public forum to allow the public an opportunity to provide comment and to solicit feedback on the progress of the Healthy Louisiana Substance Use Disorder 1115 Demonstration Waiver. The public forum will be held on Tuesday, October 17, 2023, in room 118 of the Bienville Building and via internet (Zoom) from 1:00 p.m. to 2:00 p.m. Louisiana’s most recent annual monitoring report may be reviewed by accessing the following links:
DY5 Annual Report (pending CMS approval)
Please visit the zoom link below to access the meeting: https://us06web.zoom.us/j/87993305629
Should you be unable to attend the Public Forum, you may submit comments by 4:30 p.m. on October 17, 2023, to the following email address: Ardia.Perkins@La.gov.
At any time, you may submit comments or questions to the following email address: Ardia.Perkins@La.gov.
1115 Extension Application
On December 2, 2022, the Centers for Medicare & Medicaid Services (CMS) approved Louisiana’s request to extend the Healthy Louisiana Opioid Use Disorder (OUD)/Substance Use Disorder (SUD) 1115 Demonstration Waiver. This approval is effective January 1, 2023, through December 31, 2027. Approval of this demonstration extension request will enable the state to continue to receive federal participation (FFP) for state plan services provided to otherwise eligible Medicaid beneficiaries who are primarily receiving treatment and withdrawal management services for SUD while residing in Institutions for Mental Diseases (IMDs).
- Healthy Louisiana Substance Use Disorder 1115 Demonstration Waiver approved application
- Appendix 1 – Interim Evaluation Report
- Appendix 2 – 2021 Aggregate EQRO Report
- Appendix 3 – HIT Plan
- Appendix 4 – Budget Neutrality Workbook
- Appendix 5 – Public Notice
1115 Approval and Special Terms and Conditions (STCs)
CMS approval of the demonstration waiver is conditioned on compliance with set Special Terms and Conditions (STCs). These STCs include an Implementation Protocol, SUD Monitoring Protocol, Mid-Point Assessment, and Evaluation Design and Reports. The Louisiana 1115 Approval letter contains the full list of STCs (effective February 1, 2018 through December 31, 2022) and the approved Implementation Protocol. In addition, CMS approved the SUD HIT Plan; which is the 1115 SUD Waiver Demonstration Milestone 5.0: Implementation of Strategies to Increase Utilization and Improve Functionality of PDMP.
As a response to the extension application, CMS sent the 1115 approval letter and updated STCs for Louisiana’s second 5-year waiver period (effective January 1, 2023, through December 31, 2027). CMS also approved the updated SUD HIT Plan .
The Louisiana Department of Health worked with Tulane University’s Department of Health Policy and Management to develop an evaluation design, to be used as a roadmap for conducting an evaluation of the 1115 waiver. On July 16, 2019, Louisiana received approval of the 1115 SUD Demonstration Waiver Evaluation Design.
Tulane University’s Department of Health Policy and Management, in consultation with LDH, developed an Interim Evaluation report for demonstration years 1 – 4 (2018-2021). CMS sent approval of the 1115 SUD Demonstration Waiver Interim Evaluation Report on April 19, 2023.
1115 SUD Approved Monitoring Protocol
The OBH and BHSF teams worked to align Louisiana’s 1115 SUD Monitoring Protocol with the latest versions of the CMS section 1115 SUD demonstration technical specifications manual, monitoring reporting tools, monitoring protocol tools, and other feedback received from CMS. Louisiana’s 1115 SUD Approved Monitoring Protocol encompasses: required metrics supporting the Implementation Plan milestones; various Health Information Technology (HIT) measures; certain HEDIS and other quality measures; and baseline, annual goals, and overall demonstration targets.
In accordance with the STCs, Louisiana must submit three (3) quarterly monitoring reports and one (1) compiled annual report for each Demonstration Year (DY). These reports include operational updates, performance metrics, budget neutrality and financial reporting requirements, evaluation activities and interim findings, and SUD health IT measures. All monitoring reports will be posted after CMS approval.
DY4 Q1 Monitoring Report
All archived quarterly and annual monitoring reports can be found here.